The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

Q1 2025 Management View CEO Olivier Taelman emphasized the pivotal progress toward full PMA approval in the United States, ...

Merck (MRK) stock in focus as the FDA approves its anticancer agent Welireg for two rare neuroendocrine tumors, expanding its ...

Peter Gillooly, CEO of The Wellness Company, made a formal complaint to HHS' Office of the Special Counsel and other agencies ...

The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

Ohio Attorney General Dave Yost sent letters to 14 medical spas warning them to stop making false or misleading claims about ...

Mayne Pharma is in trouble with the FDA. The agency accused Mayne of giving a misleading impression of the risks of its oral ...

The U.S. Food and Drug Administration (FDA) has issued a warning to patients and healthcare professionals regarding the use ...

The US Food and Drug Administration has issued a warning about products containing tianeptine, often called “gas station ...

Telix Pharmaceuticals excels in radiopharmaceuticals, with strong revenue growth driven by imaging products like Illuccix.

CTSO READ THE FULL CTSO RESEARCH REPORT Regulatory Update on DrugSorb-ATR On April 25, 2025, the FDA issued a denial letter regarding CytoSorbents’ (NASDAQ:CTSO) De Novo Request for DrugSorb-ATR ...

The resubmitted biologics license application for narsoplimab in transplant-associated thrombotic microangiopathy has been ...